Parathyroid Hormone-Like Changes in Renal Calcium and Phosphate Reabsorption Induced by Leydig Cell Tumor in Thyroparathyroidectomized Rats*
- 1 September 1986
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 119 (3) , 1004-1009
- https://doi.org/10.1210/endo-119-3-1004
Abstract
The Leydig cell tumor Rice H-500 is a model of humoral hypercalcemia of malignancy. Hypercalcemia is considered to result mainly from increased bone resorption. However, a change in renal tubular reabsorption of calcium (Ca) as a contributing factor to the hypercalcemia has not yet been recognized. The purpose of this study was to examine whether the renal handling of Ca was altered in Leydig cell tumor-bearing rats. To avoid counterregulations by Ca-regulating hormones, the effect of the Leydig cell tumor on plasma Ca and phosphate (Pi), urinary Ca and Pi excretion, as well as Ca and Pi renal tubular reabsorptive capacity was investigated in thyroparathyroidectomized rats. Clearance experiments were conducted at a time of tumor development when the glomerular filtration rate was not compromised. Under these conditions, tubular reabsorption of Ca was stimulated, and the maximal tubular reabsorption of Pi was markedly reduced (2.69 .+-. 0.27 vs. 4.57 .+-. 0.21 .mu.mol/min; P < 0.001). These changes were accompanied by increased urinary cAMP excretion (77.1 .+-. 6.3 vs. 34.7 .+-. 2.8 pmol/ml glomerular filtrate; P < 0.001). These results indicate that the Leydig cell tumor produces a factor with PTH-like activity on the renal tubular reabsorption of Ca and Pi. The increased tubular reabsorption of Ca may play an important role in the pathogenesis of Leydig cell tumor-induced hypercalcemia. This animal model appears to be particularly appropriate for studying the mechanisms of certain type of humoral hypercalcemia of malignancy, as some cancer patients display a change in the renal handling of Ca similar to that observed in primary hyperparathyroidism.This publication has 15 references indexed in Scilit:
- The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of the humoral hypercalcemia of malignancy in the rat leydig cell tumorCalcified Tissue International, 1983
- The hypercalcemic rat leydig cell tumor—A model of the humoral hypercalcemia of malignancyCalcified Tissue International, 1983
- Nature of calcemic effect of 1,25-dihydroxyvitamin D3 in experimental hypoparathyroidismAmerican Journal of Physiology-Endocrinology and Metabolism, 1983
- Hypercalcemia in association with a Leydig cell tumor in the rat: A model for tumor-induced hypercalcemia in manLife Sciences, 1982
- LEYDIG-CELL TUMOR INDUCED HYPERCALCEMIA IN THE FISCHER RAT - MORPHOMETRIC AND HISTOCHEMICAL EVIDENCE FOR A HUMORAL FACTOR THAT ACTIVATES OSTEOCLASTS1982
- REHYDRATION IN THE TREATMENT OF SEVERE HYPERCALCEMIA1981
- Renal handling of calcium: influence of parathyroid hormone and 1,25-dihydroxyvitamin D3American Journal of Physiology-Renal Physiology, 1979
- Effect of 1,25-Dihydroxyvitamin D3 on the Renal Handling of Pi in Thyroparathyroidectomized RatsJournal of Clinical Investigation, 1977
- Laboratory Tests in the Diagnosis of Hyperparathyroidism in Hypercalcemic PatientsAnnals of Internal Medicine, 1968
- Calcium clearance as a function of sodium clearance in the dogAmerican Journal of Physiology-Legacy Content, 1961